Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.60 |
| ▸ | RAB9A | P51151 | 3/20 | 0.60 |
| ▸ | MEN1 | O00255 | 3/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.60 |
| ▸ | ATM | Q13315 | 1/20 | 0.60 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.59 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.54 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.54 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.54 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.54 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.54 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.54 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.54 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.54 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.54 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.54 |
| ▸ | TNKS | O95271 | 1/20 | 0.54 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.54 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29779566 | 1.00 | NPC1 (0.60) | NPC1RAB9AMEN1KMT2AATM | |
| SCHEMBL333837 | 1.00 | NPC1 (0.60) | NPC1RAB9AMEN1KMT2AATM | |
| Ammonia Solution, Strong SCHEMBL28834704 | 0.98 | NPC1 (0.58) | NPC1RAB9AMEN1KMT2AATM | |
| Hydrochloric Acid SCHEMBL5200839 | 0.98 | NPC1 (0.58) | NPC1RAB9AMEN1KMT2AATM | |
| Hydrochloric Acid SCHEMBL1769092 | 0.98 | NPC1 (0.58) | NPC1RAB9AMEN1KMT2AATM | |
| Pyrrole SCHEMBL28128978 | 0.89 | HSP90AA1 (0.50) | NPC1RAB9AMEN1KMT2AATM | |
| SCHEMBL6784945 | 0.86 | NPC1 (0.54) | NPC1RAB9AMEN1KMT2AATM | |
| SCHEMBL30317323 | 0.85 | NPC1 (0.62) | NPC1RAB9AMEN1KMT2AATM | |
| SCHEMBL11999774 | 0.85 | NPC1 (0.62) | NPC1RAB9AMEN1KMT2AATM | |
| SCHEMBL11433821 | 0.84 | HCAR2 (0.71) | NPC1RAB9AMEN1KMT2AHCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 421 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118239885-A | Synthesis method of cidamine | 常州合全药业有限公司 | 2024-06-25 | — | — | CN | claimed |
| CN-112680216-B | Fluorescent probe for ammonia detection and preparation method and application of test paper thereof | 湖南超亟检测技术有限责任公司 | 2022-07-08 | — | — | CN | claimed |
| CN-112680216-A | Novel fluorescent probe for ammonia detection and preparation method and application of test paper thereof | 湖南超亟化学科技有限公司 | 2021-04-20 | — | — | CN | claimed |
| US-10297860-B2 | Lithium secondary battery | LG CHEM, LTD. (KR) | 2019-05-21 | — | — | US | claimed |
| US-9882239-B2 | Composition for gel polymer electrolyte and lithium secondary battery including the same | LG CHEM, LTD. (KR) | 2018-01-30 | — | — | US | claimed |
| EP-2431502-B1 | CYANIDE-FREE SILVER ELECTROPLATING SOLUTIONS | ROHM & HAAS ELECT MAT (US) | 2017-05-24 | — | — | EP | claimed |
| EP-2782182-B1 | LITHIUM SECONDARY BATTERY | LG CHEMICAL LTD (KR) | 2016-03-30 | — | — | EP | claimed |
| EP-2790260-B1 | COMPOSITION FOR GEL POLYMER ELECTROLYTE AND LITHIUM SECONDARY BATTERY COMPRISING SAME | LG CHEMICAL LTD (KR) | 2016-03-23 | — | — | EP | claimed |
| EP-2790260-A1 | COMPOSITION FOR GEL POLYMER ELECTROLYTE AND LITHIUM SECONDARY BATTERY COMPRISING SAME | LG Chem, Ltd. (KR) | 2014-10-15 | — | — | EP | claimed |
| EP-2782182-A1 | LITHIUM SECONDARY BATTERY | LG Chem, Ltd. (KR) | 2014-09-24 | — | — | EP | claimed |
| US-20140220452-A1 | LITHIUM SECONDARY BATTERY | LG CHEM, LTD. (KR) | 2014-08-07 | — | — | US | claimed |
| US-8608932-B2 | Cyanide-free silver electroplating solutions | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2013-12-17 | — | — | US | claimed |
| US-20120067735-A1 | CYANIDE-FREE SILVER ELECTROPLATING SOLUTIONS | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2012-03-22 | — | — | US | claimed |
| US-20070012575-A1 | Bright rhodium electrodeposition | TECHNIC, INC. | 2007-01-18 | — | — | US | claimed |
| US-20050171346-A1 | Hexahydropyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and methods of preparation | AVENTIS PHARMA S.A. (FR) | 2005-08-04 | — | — | US | claimed |
| US-5995869-A | Reduction of skin sensitization in electrotransport drug delivery | ALZA CORPORATION (US) | 1999-11-30 | — | — | US | claimed |
| US-5939268-A | DIELS-ALDER REACTION PRODUCT OF A DIENE AND A DIENOPHILE; CHEMICAL INTERMEDIATES FOR DRUGS, SOLID PHASE SYNTHESIS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1999-08-17 | — | — | US | claimed |
| WO-1997047355-A1 | REDUCTION OF SKIN SENSITIZATION IN ELECTROTRANSPORT DRUG DELIVERY | ALZA CORPORATION (US) | 1997-12-18 | — | — | WO | claimed |
| EP-0773953-A1 | COMBINATORIAL LIBRARIES OF MOLECULES AND METHODS FOR PRODUCING SAME | THE SCRIPPS INSTITUTE (US) | 1997-05-21 | — | — | EP | claimed |
| WO-1996003424-A1 | COMBINATORIAL LIBRARIES OF MOLECULES AND METHODS FOR PRODUCING SAME | THE SCRIPPS RESEARCH INSTITUTE (US) | 1996-02-08 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050171346-A1 | Hexahydropyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and methods of preparation | HEXD, CDK5, CHUK | NPC1 2615/4885RAB9A 3051/4885MEN1 1864/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.